Z-2159-2012 Class III Terminated
FDA device recall Z-2159-2012 was initiated by Roche Molecular Systems, Inc. on Feb 24, 2012 and is designated Class III. Reason for recall: During the real-time stability testing for the cobas KRAS Mutation Test on the commercial lot PO6778, it was identified that the kit was just within specifications for the codon 61 peak height ratio… The recall status is terminated (terminated Jul 16, 2013). Affected quantity: 264 kits to 13 EU countries; 2 kits to Canada and 33 kits to 11 countries in the Rest of the World.
Recall details
- Product Type
- Devices
- Report Date
- Aug 15, 2012
- Initiation Date
- Feb 24, 2012
- Termination Date
- Jul 16, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 264 kits to 13 EU countries; 2 kits to Canada and 33 kits to 11 countries in the Rest of the World
Product description
Reason for recall
Distribution pattern
Worldwide Distribution - including the countries of Austria, Belgium, Czech Republic, Denmark, Germany, Italy, Luxemburg, Netherlands, Poland, Slovakia, Slovenia, Spain, United Kingdom, Canada, Chile, Greenland, Hong Kong, Israel, Malaysia, New Zealand, Philippines, S. Africa, Switzerland, Taiwan and Turkey.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2159-2012
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026